Literature DB >> 22112486

Preneoplasia of lung cancer.

Adi F Gazdar1, Elisabeth Brambilla.   

Abstract

As with other epithelial cancers, lung cancer develops over a period of several years or decades via a series of progressive morphological changes accompanied by molecular alterations that commence in histologically normal epithelium. However the development of lung cancer presents certain unique features that complicates this evaluation. Anatomically the respiratory tree may be divided into central and peripheral compartments having different gross and histological anatomies as well as different functions. In addition, there are three major forms of lung cancer and many minor forms. Many of these forms arise predominantly in either the central or peripheral compartments. Squamous cell and small cell carcinomas predominantly arise in the central compartment, while adenocarcinomas predominantly arise peripherally. Large cell carcinomas are not a single entity but consist of poorly differentiated forms of the other types and, possibly, some truly undifferentiated "stem cell like" tumors. The multistage origin of squamous cell carcinomas, because of their central location, can be followed more closely than the peripherally arising adenocarcinomas. Squamous cell carcinomas arise after a series of reactive, metaplastic, premalignant and preinvasive changes. However, long term observations indicate that not all tumors follow a defined histologic course, and the clinical course, especially of early lesions, is difficult to predict. Peripheral adenocarcinomas are believed to arise from precursor lesions known as atypical adenomatous hyperplasias and may have extensive in situ growth before becoming invasive. Small cell carcinomas are believed to arise from severely molecularly damaged epithelium without going through recognizable preneoplastic changes. The molecular changes that occur prior to the onset on invasive cancers are extensive. As documented in this chapter, they encompass all of the six classic Hallmarks of Cancer other than invasion and metastasis, which by definition occur beyond preneoplasia. A study of preinvasive lung cancer has yielded much valuable biologic information that impacts on clinical management.

Entities:  

Mesh:

Year:  2010        PMID: 22112486      PMCID: PMC3428013          DOI: 10.3233/CBM-2011-0166

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  62 in total

Review 1.  Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug development.

Authors:  Gary J Kelloff; Caroline C Sigman
Journal:  Nat Rev Cancer       Date:  2007-07       Impact factor: 60.716

Review 2.  The new World Health Organization classification of lung tumours.

Authors:  E Brambilla; W D Travis; T V Colby; B Corrin; Y Shimosato
Journal:  Eur Respir J       Date:  2001-12       Impact factor: 16.671

3.  Molecular changes in the bronchial epithelium of patients with small cell lung cancer.

Authors:  I I Wistuba; J Berry; C Behrens; A Maitra; N Shivapurkar; S Milchgrub; B Mackay; J D Minna; A F Gazdar
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

4.  Overexpression of Dicer in precursor lesions of lung adenocarcinoma.

Authors:  Simion Chiosea; Elena Jelezcova; Uma Chandran; Jianhua Luo; Geeta Mantha; Robert W Sobol; Sanja Dacic
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

5.  Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease.

Authors:  Susan J Davies; John R Gosney; David M Hansell; Athol U Wells; Roland M du Bois; Margaret M Burke; Mary N Sheppard; Andrew G Nicholson
Journal:  Thorax       Date:  2006-11-10       Impact factor: 9.139

Review 6.  Lung cancer preneoplasia.

Authors:  Ignacio I Wistuba; Adi F Gazdar
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

Review 7.  Lung cancer in never smokers--a different disease.

Authors:  Sophie Sun; Joan H Schiller; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

8.  Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.

Authors:  H-S Hsu; T-P Chen; C-K Wen; C-H Hung; C-Y Chen; J-T Chen; Y-C Wang
Journal:  J Pathol       Date:  2007-12       Impact factor: 7.996

9.  Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer.

Authors:  Marileila Varella-Garcia; Lin Chen; Roger L Powell; Fred R Hirsch; Timothy C Kennedy; Robert Keith; York E Miller; John D Mitchell; Wilbur A Franklin
Journal:  Am J Respir Crit Care Med       Date:  2007-06-28       Impact factor: 21.405

10.  Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases.

Authors:  Mary Wahbah; Nahal Boroumand; Claudia Castro; Faten El-Zeky; Mahmoud Eltorky
Journal:  Ann Diagn Pathol       Date:  2007-04       Impact factor: 2.090

View more
  9 in total

1.  Human tumor necrosis factor alpha-induced protein eight-like 1 exhibited potent anti-tumor effect through modulation of proliferation, survival, migration and invasion of lung cancer cells.

Authors:  Devivasha Bordoloi; Ganesan Padmavathi; Kishore Banik; Khwairakpam Amrita Devi; Choudhary Harsha; Sosmitha Girisa; Constanze Buhrmann; Mehdi Shakibaei; Ajaikumar B Kunnumakkara
Journal:  Mol Cell Biochem       Date:  2021-04-25       Impact factor: 3.396

2.  The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung.

Authors:  Adi F Gazdar; Trisha K Savage; Jane E Johnson; Anton Berns; Julien Sage; R Ilona Linnoila; David MacPherson; David G McFadden; Anna Farago; Tyler Jacks; William D Travis; Elisabeth Brambilla
Journal:  J Thorac Oncol       Date:  2015-04       Impact factor: 15.609

3.  The cholesterol-binding protein NPC2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours.

Authors:  Tamihiro Kamata; Hong Jin; Susan Giblett; Bipin Patel; Falguni Patel; Charles Foster; Catrin Pritchard
Journal:  EMBO Mol Med       Date:  2015-09       Impact factor: 12.137

4.  Maspin expression patterns differ in the invasive versus lepidic growth pattern of pulmonary adenocarcinoma.

Authors:  Fulvio Lonardo; Hui Guan; Sijana Dzinic; Shijie Sheng
Journal:  Histopathology       Date:  2014-09-09       Impact factor: 5.087

Review 5.  Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis.

Authors:  Erin A Marshall; Kevin W Ng; Sonia H Y Kung; Emma M Conway; Victor D Martinez; Elizabeth C Halvorsen; David A Rowbotham; Emily A Vucic; Adam W Plumb; Daiana D Becker-Santos; Katey S S Enfield; Jennifer Y Kennett; Kevin L Bennewith; William W Lockwood; Stephen Lam; John C English; Ninan Abraham; Wan L Lam
Journal:  Mol Cancer       Date:  2016-10-27       Impact factor: 27.401

Review 6.  Genetic Markers in Lung Cancer Diagnosis: A Review.

Authors:  Katarzyna Wadowska; Iwona Bil-Lula; Łukasz Trembecki; Mariola Śliwińska-Mossoń
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

7.  The evolutionary history of 2,658 cancers.

Authors:  Moritz Gerstung; Clemency Jolly; Ignaty Leshchiner; Stefan C Dentro; Santiago Gonzalez; Daniel Rosebrock; Thomas J Mitchell; Yulia Rubanova; Pavana Anur; Kaixian Yu; Maxime Tarabichi; Amit Deshwar; Jeff Wintersinger; Kortine Kleinheinz; Ignacio Vázquez-García; Kerstin Haase; Lara Jerman; Subhajit Sengupta; Geoff Macintyre; Salem Malikic; Nilgun Donmez; Dimitri G Livitz; Marek Cmero; Jonas Demeulemeester; Steven Schumacher; Yu Fan; Xiaotong Yao; Juhee Lee; Matthias Schlesner; Paul C Boutros; David D Bowtell; Hongtu Zhu; Gad Getz; Marcin Imielinski; Rameen Beroukhim; S Cenk Sahinalp; Yuan Ji; Martin Peifer; Florian Markowetz; Ville Mustonen; Ke Yuan; Wenyi Wang; Quaid D Morris; Paul T Spellman; David C Wedge; Peter Van Loo
Journal:  Nature       Date:  2020-02-06       Impact factor: 49.962

8.  TIPE2 Induced the Proliferation, Survival, and Migration of Lung Cancer Cells Through Modulation of Akt/mTOR/NF-κB Signaling Cascade.

Authors:  Devivasha Bordoloi; Kishore Banik; Ganesan Padmavathi; Rajesh Vikkurthi; Choudhary Harsha; Nand Kishor Roy; Anuj Kumar Singh; Javadi Monisha; Hong Wang; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Biomolecules       Date:  2019-12-06

9.  FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.

Authors:  Giustina Ferone; Ji-Ying Song; Oscar Krijgsman; Jan van der Vliet; Miranda Cozijnsen; Ekaterina A Semenova; David J Adams; Daniel Peeper; Anton Berns
Journal:  Cell Rep       Date:  2020-03-17       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.